Shares of SkinBioTherapeutics plc (LON:SBTX – Get Free Report) shot up 7.5% during mid-day trading on Friday . The company traded as high as GBX 14.40 ($0.19) and last traded at GBX 14.25 ($0.19). 1,388,314 shares were traded during trading, an increase of 48% from the average session volume of 938,188 shares. The stock had previously closed at GBX 13.25 ($0.17).
SkinBioTherapeutics Stock Performance
The company has a debt-to-equity ratio of 2.66, a current ratio of 6.57 and a quick ratio of 10.01. The firm has a market cap of £36.46 million, a price-to-earnings ratio of -806.25 and a beta of 2.01. The company has a fifty day moving average price of GBX 12.20 and a two-hundred day moving average price of GBX 10.86.
SkinBioTherapeutics Company Profile
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Read More
- Five stocks we like better than SkinBioTherapeutics
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- EV Stocks and How to Profit from Them
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
